Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts

Jin Zhou; Xiang-mei Chen; Shu-wen Liu; Bo Fu; Quan Hong; Shu-juan Wang

doi:10.1007/s11655-014-1784-0

Your Location：

Home >

Browse articles >

Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts

OriginalPaper | Updated：2021-08-27

- Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts
- Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts
- 中国结合医学杂志（英文版） 2015年21卷第2期页码：152-156
- Affiliations：
  
  1. Department of Nephrology, the PLA General Hospital,Beijing,China
  2. Department of Medical Records, the PLA General Hospital,Beijing,China
- Author bio：
- Funds：
  
  Supported by the National Science Foundation of China (No. 30130220 and No. 30873345);National Natural Science Found for Innovative Research Groups Science Foundation of China (No. 30121005)
- DOI：10.1007/s11655-014-1784-0
  中图分类号：
- 纸质出版日期：2015，
  
  网络出版日期：2014-12-16，
Scan for full text
Zhou, J., Chen, Xm., Liu, Sw. et al. Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts., Chin. J. Integr. Med. 21, 152–156 (2015). https://doi.org/10.1007/s11655-014-1784-0

Jin Zhou, Xiang-mei Chen, Shu-wen Liu, et al. Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts[J]. Chinese Journal of Integrative Medicine, 2015,21(2):152-156.
Zhou, J., Chen, Xm., Liu, Sw. et al. Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts., Chin. J. Integr. Med. 21, 152–156 (2015). https://doi.org/10.1007/s11655-014-1784-0 DOI：

Jin Zhou, Xiang-mei Chen, Shu-wen Liu, et al. Effects of Biejia Ruangan Tablet (复方鳖甲软肝片)-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts[J]. Chinese Journal of Integrative Medicine, 2015,21(2):152-156. DOI： 10.1007/s11655-014-1784-0.

摘要

To investigate the effects of Biejia Ruangan Tablet (复方鳖甲软肝片方

BRT)-containing serum on the expression of matrix metalloproteinase (MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) in cultured renal interstitial fibroblasts. Different BRT-containing sera were prepared by gastric gavages to rats with the high-dose (7 g/kg)

mid-dose (3.5 g/kg)

and low-dose (1.75 g/kg) BRT respectively. The expression of extracellular matrix in NRK-49F cells was induced by treatment with human transforming growth factor-β1 (recombined human TGF-β1)

and BRT-containing serum. Western blotting and Northern blotting were used to measure type I and III procollagen

MMP-9

and TIMP-1. The high dose BRT-containing serum could decrease the type I and III procollagen gene expression which boosted by TGF-β1

at the same time cut down TIMP-1 protein and gene expression which increased by TGF-β1 (P <0.05). Treatment of cells with recombined human TGF-β1 had no significant effect on MMP-9 expression and BRT-containing serum also had no effect on MMP-9 expression. High dose BRT has anti-fibrosis effects in NRK-49F cells

as indicated by its inhibition of type I and III procollagen and TIMP-1 expression.

Abstract

To investigate the effects of Biejia Ruangan Tablet (复方鳖甲软肝片方

mid-dose (3.5 g/kg)

and low-dose (1.75 g/kg) BRT respectively. The expression of extracellular matrix in NRK-49F cells was induced by treatment with human transforming growth factor-β1 (recombined human TGF-β1)

and BRT-containing serum. Western blotting and Northern blotting were used to measure type I and III procollagen

MMP-9

and TIMP-1. The high dose BRT-containing serum could decrease the type I and III procollagen gene expression which boosted by TGF-β1

as indicated by its inhibition of type I and III procollagen and TIMP-1 expression.

关键词

renal interstitial fibroblastsBiejia Ruangan Tablettype I and III procollagenmatrix metalloproteinase -9tissue inhibitor of metalloproteinase -1

Keywords

renal interstitial fibroblastsBiejia Ruangan Tablettype I and III procollagenmatrix metalloproteinase -9tissue inhibitor of metalloproteinase -1

references

Zhou GD, Li WS, Zhao JM, Sun YL, Pan D, Yang JF, et al. Clinical pathological study on the mechanism of effect of Fufang Biejia Ruangan Tablet in treatment of liver fibrosis. Med J Chin PLA (Chin) 2004;29:563–564.

Ke W, Zhu JH. Progresses of research in method of serum-pharmacology of Chinese herbs. Guide China Med (Chin) 2011;9:24–26.

Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damages. Am J Kidney Dis 1992;20:1–17.

Kramann R, Dirocco DP, Maarouf OH, Humphreys BD. Matrix producing cells in chronic kidney disease: origin, regulation, and activation. Curr Pathobiol Rep 2013;1:26–27.

Docherty NG, Godson C. Fibrinogen as a damage-associated mitogenic signal for the renal fibroblast. Kidney Int 2011;80:1014–1016.

Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495–2508.

Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70–76.

López-Hernández FJ, López-Novoa JM. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 2012;347:141–154.

Cai ZH, Liu W, Li Q, Wu XL, Qian YL, Cao YL. Blocking transforming growth factor β1 signaling decreases dermal fibroblast proliferation and type I collagen production. Chin J Exp Surg (Chin) 2003;20:160–161.

Lin HY, Wang HM, Zhu C. Regulation of matrix metalloproteinases and their tissue inhibitors by transforming growth factor-β. Prog Biochem Biophy (Chin) 2003;30:7–12.

Han Y P, Tuan T L, Hughes M, Shaw MC, Garner WL. Transforming growth factor-β1 and tumor necrosis factor-α-mediated induction and priteolytic activation of MMP-9 in human skin. J Biol Chem 2001;276:22341–22350.

Johansson N, Ala-aho R, Uitto V, Grénman R, Fusenig NE, López-Otín C, et al. Expression of collagenase-3 (MMP-3) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000;113:227–235.

Martin J, Steadman R, Knowlden J, Williams J, Davies M. Differential regulation of matrix metalloproteinases and their inhibitors in human golmerular epithelial cells in vitro. J Am Soc Nephrol 1998;9:1629–1637.

Chen DY, Yang YP. Clinical observation of phase II of therapeutic effect of composed Amyda Sinensis Soft Liver Tablet on hepatic fibrosis of chronic hepatitis B. Infect Dis Inf (Chin) 1999;12:61–62.

Shen WZ, Xie ZW, Cai JH, Lu HM, Lv HM. Effect of Complex Biejia Ruangan Tablet on renal transforming growth factor-β1 expression in rat model with chronic renal failure. Chin J Integr Tradit West Nephrol (Chin) 2006;7:570–573.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

暂无数据